{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:09:06Z","timestamp":1770815346254,"version":"3.50.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>In T-cell lymphoma, the role of FDG PET for bone marrow (BM) evaluation is not established yet. We investigated diagnostic performance and prognostic implication of FDG PET for BM evaluation in peripheral T-cell lymphoma (PTCL) and extranodal NK\/T-cell lymphoma (NKTCL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>Patients with PTCL or NKTCL, who underwent initial staging with FDG PET and BM biopsy, were retrospectively enrolled and analyzed. PET BM finding was evaluated using visual analysis and a quantitative index (marrow-to-liver ratio [MLR]). Diagnostic performance of PET for BM involvement was assessed with biopsy as the gold standard. Prognostic value of PET findings was also assessed regarding progression-free survival (PFS) and overall survival (OS).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 109 (63 PTCL and 46 NKTCL) patients were analyzed. Biopsy revealed BM involvement in 35.8% of cases. Sensitivity and specificity of PET for diagnosing positive BM biopsy were 61.5% and 75.7% by visual analysis and 64.1% and 72.9% by MLR. Diagnostic performance of PET was not different across lymphoma types. Survival analysis revealed that MLR and BM biopsy result is significant for both PFS and OS. In multivariate analysis, MLR was an independent prognostic factor for both PFS and OS. Marrow-to-liver ratio was also a significant prognostic factor in BM biopsy-negative patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Despite fair correlation with BM biopsy result, PET may not replace BM biopsy in PTCL and NKTCL. However, the BM finding on PET is an independent prognostic factor, suggesting additional biological implication of PET findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000002320","type":"journal-article","created":{"date-parts":[[2018,10,29]],"date-time":"2018-10-29T03:26:37Z","timestamp":1540783597000},"page":"4-10","source":"Crossref","is-referenced-by-count":27,"title":["FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Youngil","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Seoul National University Hospital; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Go-Un","family":"Woo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Chul","family":"Paeng","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Seoul National University Hospital; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeonghwan","family":"Youk","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Soo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keon Wook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/annonc\/mdw137","article-title":"The value of routine bone marrow biopsy in patients with diffuse large B-cell lymphoma staged with PET\/CT: a Danish-Canadian study","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.14071","article-title":"(18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma","volume":"174","year":"2016","journal-title":"Br J Haematol"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"608","DOI":"10.6004\/jnccn.2017.0064","article-title":"Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"196","DOI":"10.6004\/jnccn.2016.0023","article-title":"Diffuse Large B-Cell Lymphoma Version 1.2016","volume":"14","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12185-014-1520-3","article-title":"Peripheral T cell lymphoma in Asia","volume":"99","year":"2014","journal-title":"Int J Hematol"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(09)70265-7","article-title":"Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009","volume":"10","year":"2009","journal-title":"Lancet Oncol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1182\/blood-2010-05-231548","article-title":"Peripheral T-cell lymphoma","volume":"117","year":"2011","journal-title":"Blood"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1182\/blood-2013-12-516245","article-title":"How I treat the peripheral T-cell lymphomas","volume":"123","year":"2014","journal-title":"Blood"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-017-0452-9","article-title":"The diagnosis and management of NK\/T-cell lymphomas","volume":"10","year":"2017","journal-title":"J Hematol Oncol"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.6004\/jnccn.2014.0125","article-title":"Non-Hodgkin's lymphomas, version 4.2014","volume":"12","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"bib11-20230925","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1182\/blood-2013-01-453233","article-title":"How I treat NK\/T-cell lymphomas","volume":"121","year":"2013","journal-title":"Blood"},{"key":"bib12-20230925","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/bjh.14473","article-title":"How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future","volume":"176","year":"2017","journal-title":"Br J Haematol"},{"key":"bib13-20230925","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/annonc\/mdw011","article-title":"Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET\/CT in patients with peripheral T-cell lymphoma (PTCL)","volume":"27","year":"2016","journal-title":"Ann Oncol"},{"key":"bib14-20230925","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/annonc\/mdv010","article-title":"Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma","volume":"26","year":"2015","journal-title":"Ann Oncol"},{"key":"bib15-20230925","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1080\/10428194.2017.1300891","article-title":"Accuracy of 18-F FDG PET\/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma - tissue remains the issue","volume":"58","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"bib16-20230925","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajh.24128","article-title":"Utility of interim and end-of-treatment PET\/CT in peripheral T-cell lymphomas: a review of 124 patients","volume":"90","year":"2015","journal-title":"Am J Hematol"},{"key":"bib17-20230925","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00277-014-2289-4","article-title":"Evaluation of bone marrow involvement in extranodal NK\/T cell lymphoma by FDG-PET\/CT","volume":"94","year":"2015","journal-title":"Ann Hematol"},{"key":"bib18-20230925","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.18632\/oncotarget.13873","article-title":"Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET\/CT in extra-nodal NK\/T-cell lymphoma","volume":"8","year":"2017","journal-title":"Oncotarget"},{"key":"bib20-20230925","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting","volume":"7","year":"1989","journal-title":"J Clin Oncol"},{"key":"bib21-20230925","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3322\/canjclin.55.6.368","article-title":"Staging non-Hodgkin lymphoma","volume":"55","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"bib22-20230925","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival model predictive accuracy and ROC curves","volume":"61","year":"2005","journal-title":"Biometrics"},{"key":"bib23-20230925","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","year":"2012","journal-title":"PLoS One"},{"key":"bib24-20230925","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1634\/theoncologist.2014-0305","article-title":"A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I\/II extranodal natural killer\/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group","volume":"19","year":"2014","journal-title":"Oncologist"},{"key":"bib25-20230925","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1200\/JCO.2006.09.4474","article-title":"Identification of a proliferation signature related to survival in nodal peripheral T-cell lymphomas","volume":"25","year":"2007","journal-title":"J Clin Oncol"},{"key":"bib26-20230925","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2004.05144.x","article-title":"Bone marrow histopathology in peripheral T-cell lymphomas","volume":"127","year":"2004","journal-title":"Br J Haematol"},{"key":"bib27-20230925","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.blre.2016.09.006","article-title":"Monitoring minimal residual disease in acute leukemia: technical challenges and interpretive complexities","volume":"31","year":"2017","journal-title":"Blood Rev"},{"key":"bib28-20230925","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1182\/blood-2015-03-580027","article-title":"Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies","volume":"125","year":"2015","journal-title":"Blood"},{"key":"bib29-20230925","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ajh.24629","article-title":"Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission","volume":"92","year":"2017","journal-title":"Am J Hematol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201901000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:11:55Z","timestamp":1695618715000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201901000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002320","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}